As of August 2026, 17 paid clinical trials are recruiting in Norwich, Connecticut. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Norwich offers studies at sites including Eastern Connecticut Hematology and Oncology Associates for conditions such as Advanced Solid Tumors, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Advanced Non-Small Cell Lung Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Researchers run research studies in Norwich, CT at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Eastern Connecticut Hematology and Oncology Associates | Advanced Non-Small Cell Lung Cancer, Advanced Solid Tumors, Advanced/Metastatic Urothelial Cancer | 5 |
| Eastern CT and Hematology and Oncology Associates | Cancer, Non-Small Cell Lung Cancer | 2 |
| Eastern Connecticut Hematology and Oncology | Cancer, Chronic Lymphocytic Leukemia, Immune Checkpoint Therapy | 2 |
| Eastern CT Hematology & Oncology Associates | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Carcinoma, Non-Small-Cell Lung | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Transthyretin Amyloidosis With Cardiomyopathy | 1 |
| Eastern Connecticut Hematology & Oncology | Cancer-associated Cachexia | 1 |
| Eastern Connecticut Hematology Oncology | Chemotherapy Induced Peripheral Neuropathy (CIPN) | 1 |
| United Community & Family Services | Problem Gambling | 1 |
| William W. Backus Hospital | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Multiple Myeloma | 1 |
Recruiting trials in Norwich grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
There are approximately 17 recruiting clinical trials in Norwich, Connecticut listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Norwich compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Norwich include Advanced Solid Tumors (2), Cancer (2), Chronic Lymphocytic Leukemia (2), Small Lymphocytic Lymphoma (2), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Norwich on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Norwich include Eastern Connecticut Hematology and Oncology Associates, Eastern CT and Hematology and Oncology Associates, Eastern Connecticut Hematology and Oncology, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Norwich are Cancer & tumors (14). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.